Riya Sharma  Erstellt neuen Artikel
1 w ·übersetzen

Global Temozolomide Market Set for Strong Growth Driven by Rising Cancer Incidence and Advancements in Chemotherapy | #temozolomide Market

Global Temozolomide Market Set for Strong Growth Driven by Rising Cancer Incidence and Advancements in Chemotherapy

Global Temozolomide Market Set for Strong Growth Driven by Rising Cancer Incidence and Advancements in Chemotherapy

The global Temozolomide Market is on an upward trajectory, fueled by the increasing prevalence of brain cancers and glioblastomas. Valued at USD 260 million in 2023, the market is projected to surpass USD 420 million by 2032, expanding at a robust CAGR of 5.6% over the forecast period.